推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

MEDICINAL RESEARCH REVIEWS 期刊收藏夹

2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
聚合物期刊JPM征稿|IF持续上升 + APC折扣
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


MEDICINAL RESEARCH REVIEWS期刊基本信息Hello,您是该期刊的第79631位访客


基本信息 登录收藏
期刊名字MEDICINAL RESEARCH REVIEWSMEDICINAL RESEARCH REVIEWS

MED RES REV
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.2
65人评分
我要评分

声誉
9.2

影响力
7.8

速度
6.4

期刊ISSN0198-6325
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1098-1128
2024-2025最新影响因子
(数据来源于搜索引擎)
11.6 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日:13.51
2024-2025自引率0.0%点击查看自引率趋势图
五年影响因子13.8
JCI期刊引文指标 1.61
h-index 119
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
29.103.2653.042
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q12 / 161
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q15 / 328
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q15 / 179

期刊简介
Medicinal Research Reviews publishes timely, critical reviews and opinion-based articles on topics related to medicinal research, broadly defined, to which the authors have made significant contributions.

Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs.

Articles are mainly solicited by the Editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline (see below) before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1128
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址http://mc.manuscriptcentral.com/med
该期刊中国学者近期发文 - NewAldo-Keto Reductase Family 1 Member B10 as a Therapeutic Frontier: Advances in Inhibitor Design and Multimodal Approaches
Author: Shao, Jikuan; Wang, Xiaolong; Guo, Can; Xing, Shuaishuai; Sun, Haopeng
Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70050


Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity
Author: Dong, Shixuan; Xu, Ying; Gan, Ran; Zhang, Ailin; He, Jinhan; Tang, Qin
Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70049


Unravelling Structure-Based Molecular Activation and Antagonism of Protease-Activated Receptors for Drug Design
Author: Xu, Zhikang; Li, Rui; Zhang, Jian
Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70048


Comparative Pharmacology of Caspase-1 Inhibitors: Ac-YVAD-CMK, Z-YVAD-FMK, and Ac-YVAD-CHO in Multisystem Diseases
Author: Zheng, Yujia; Dou, Baolei; Ren, Yifan; Zhang, Xiangyi; Zhang, Ruifeng; Zhang, Guangming; Yang, Lin; Zeng, Miao; Gan, Jiali; Jiang, Xijuan; Xu, Pengjuan
Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70045


期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足MEDICINAL RESEARCH REVIEWS的语言要求,还能让MEDICINAL RESEARCH REVIEWS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被MEDICINAL RESEARCH REVIEWS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030
出版商John Wiley and Sons Inc.
涉及的研究方向医学-药学
出版国家或地区UNITED STATES
出版语言English
出版周期Bimonthly
出版年份1981
年文章数 68点击查看年文章数趋势图
Gold OA文章占比18.23%
研究类文章占比:
文章 ÷(文章 + 综述)
2.94%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MEDICINALSCIEQ11/72
学科:PHARMACOLOGY & PHARMACYSCIEQ111/352
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CHEMISTRY, MEDICINALSCIEQ13/72
学科:PHARMACOLOGY & PHARMACYSCIEQ122/353
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
CHEMISTRY, MEDICINAL
药物化学
4区1区1区
PHARMACOLOGY & PHARMACY
药学
4区4区1区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区2区
CHEMISTRY, MEDICINAL
药物化学
3区3区1区
PHARMACOLOGY & PHARMACY
药学
2区3区1区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
CHEMISTRY, MEDICINAL
药物化学
4区4区1区
PHARMACOLOGY & PHARMACY
药学
3区2区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0198-6325%5BISSN%5D
平均审稿速度网友分享经验:
约稿?周期不定
平均录用比例网友分享经验:
多是约稿
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在MEDICINAL RESEARCH REVIEWS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 MEDICINAL RESEARCH REVIEWS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 MEDICINAL RESEARCH REVIEWS期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
MEDICINAL RESEARCH REVIEWS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    DRUG RESISTANCE UPDATES10029.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20132.40
    ADVANCED DRUG DELIVERY REVIEWS27839.00
    PHARMACOLOGICAL REVIEWS21025.90
    PHARMACOLOGY & THERAPEUTICS18028.30
    PHARMACOLOGICAL RESEARCH11819.10
    PHYTOMEDICINE10513.20
    DRUG DELIVERY5220.20
    BRITISH JOURNAL OF PHARMACOLOGY19013.50
    DRUG DISCOVERY TODAY15716.80
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE883331
    JOURNAL OF ETHNOPHARMACOLOGY790287
    Frontiers in Immunology726517
    BIOMEDICINE & PHARMACOTHERAPY713603
    BIOMATERIALS705388
    Frontiers in Pharmacology699659
    PHYTOMEDICINE625941
    Frontiers in Oncology608456
    IEEE Journal of Biomedical and Health Informatics582387
    Biomedical Signal Processing and Control582059
  •  

    MEDICINAL RESEARCH REVIEWS MEDICINAL RESEARCH REVIEWS
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Aldo-Keto Reductase Family 1 Member B10 as a Therapeutic Frontier: Advances in Inhibitor Design and Multimodal Approaches

    Author: Shao, Jikuan; Wang, Xiaolong; Guo, Can; Xing, Shuaishuai; Sun, Haopeng
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70050
        PubMed      DOI
    2.Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity

    Author: Dong, Shixuan; Xu, Ying; Gan, Ran; Zhang, Ailin; He, Jinhan; Tang, Qin
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70049
        PubMed      DOI
    3.Unravelling Structure-Based Molecular Activation and Antagonism of Protease-Activated Receptors for Drug Design

    Author: Xu, Zhikang; Li, Rui; Zhang, Jian
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70048
        PubMed      DOI
    4.Comparative Pharmacology of Caspase-1 Inhibitors: Ac-YVAD-CMK, Z-YVAD-FMK, and Ac-YVAD-CHO in Multisystem Diseases

    Author: Zheng, Yujia; Dou, Baolei; Ren, Yifan; Zhang, Xiangyi; Zhang, Ruifeng; Zhang, Guangming; Yang, Lin; Zeng, Miao; Gan, Jiali; Jiang, Xijuan; Xu, Pengjuan
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70045
        PubMed      DOI
    5.Mucin O-Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review

    Author: Zhao, Qi-Di; Morris, David L.; Sun, Zheng-Long; Li, Yan
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70051
        PubMed      DOI
    6.Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions

    Author: Bai, Linyue; Shen, Liang; Zhang, Qianqian; Hu, Zhuang; Tang, Yanjun; Fu, Mengjie; Fan, Yange; Wang, Huifeng; Liu, Hong-Min; Dai, Xing-Jie; Feng, Siqi
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70034
        PubMed      DOI
    7.Recent Advances of Non-Nucleoside Polymerase Inhibitors With Broad-Spectrum Antiviral Activities

    Author: Tao, Sining; Zhou, Zhenzhen; Li, Xin; Wang, Xian-wei; Liu, Xinyong; Kang, Dongwei
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70041
        PubMed      DOI
    8.A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunities

    Author: Xu, Yi-Xin; Bai, Yi-Ru; Li, Ruifang; Peng, Yi-Ming; Liu, Ting-Ting; Yang, Xin; Chen, Ke-Tong; Jin, Zhi-Peng; Liu, Hong-Min; Yuan, Shuo
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70035
        PubMed      DOI
    9.Unlocking Multiscale Allosteric Mechanisms: Advanced Computational Strategies for Drug Discovery

    Author: Zhu, Ruidi; Wu, Chengwei; Li, Mingyu; Liu, Xinyi; Zhang, Jian
    Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70036
        PubMed      DOI
    10.3D Bioprinting for Engineering Organoids and Organ-on-a-Chip: Developments and Applications

    Author: Ren, Yuqing; Yuan, Congying; Liang, Qimeng; Ba, Yuhao; Xu, Hui; Weng, Siyuan; Zhang, Yuyuan; Zuo, Anning; Liu, Shutong; Luo, Peng; Chen, Quan; Zhou, Zhaokai; Zhang, Chuhan; Chen, Yukang; Liu, Zaoqu; Han, Xinwei
    Journal: MEDICINAL RESEARCH REVIEWS. 2025; Vol. , Issue , pp. -. DOI: 10.1002/med.22121
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS DRUG DISCOVERY289159.20
    Kidney International Supplements24117.70
    LANCET70092.40
    Nature Reviews Clinical Oncology127126.60
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    NATURE REVIEWS CANCER39696.20
    World Psychiatry6184.80
    World Psychiatry7084.80
    ANNALS OF ONCOLOGY21069.60
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS MICROBIOLOGY250124.00
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    Kidney International Supplements24117.70
    LANCET70092.40
    Nature Reviews Materials61110.60
    Nature Reviews Clinical Oncology127126.60
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Nature Reviews Earth & Environment098.90
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共148


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室